申请人:Olatec Industries LLC
公开号:US20150087701A1
公开(公告)日:2015-03-26
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a ω-(arylsulfonyl)alkylnitrile compound, or a pharmaceutically acceptable salt thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering an ω-(arylsulfonyl)alkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
本发明涉及一种药物组合物,包括一种药用载体和一种ω-(芳基磺酰基)烷基腈化合物或其药用可接受盐。本发明还涉及一种治疗炎症、炎症相关疾病或疼痛的方法,通过向需要的受体给予ω-(芳基磺酰基)烷基腈化合物或其药用可接受盐或溶剂。